{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-21-005846","form_type":"8-K","ticker":"CNBX","cik":"0001343009","company_name":"CNBX Pharmaceuticals Inc.","filed_at":"2021-11-19T23:59:59+00:00","discovered_at":"2026-05-14T18:04:12.198682+00:00","generated_at":"2026-06-28T06:27:59.919733+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Cannabics appoints Shaul Yemal to Board as independent director and Audit Committee member","bullets":["Board expanded to five members; Shaul Yemal appointed as independent director and Audit Committee member.","Yemal brings transnational finance experience, including roles at Israeli Ministry of Finance and Ministry of Energy.","Previously CEO of ICL Santiago, Senior VP at ISAL Amlat VC Fund, and catalyst for Oridion Medical's IPO on Swiss exchange.","No arrangements or understandings with any other person; no related party transactions disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-21-005846","json":"https://secwatch.observer/filing/0001683168-21-005846.json","markdown":"https://secwatch.observer/filing/0001683168-21-005846.md","text":"https://secwatch.observer/filing/0001683168-21-005846.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1343009/000168316821005846/0001683168-21-005846-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1343009/000168316821005846/cannabics_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T06:27:59.919733+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"57f4b1bb47","claim":"Shaul Yemal was appointed as Independent Director at CNBX Pharmaceuticals Inc..","evidence_excerpt":"On November 16 th , 2021, the Board of Directors (the “Board”) increased the size of the Board to five (5) members, and appointed Mr. Shaul Yemal to the Board as an Independent Director and as a member of the Audit Committee.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1343009/000168316821005846/0001683168-21-005846-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Independent Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}